Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome (SARS) Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05541861
What this trial is testing

Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 383
Early research (Phase 1)Study completedNCT05263921
What this trial is testing

Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Bioavailability
Pfizer 12
Post-approval studies (Phase 4)Study completedNCT04340557
What this trial is testing

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

Who this might be right for
SARS-CoV Infection
Sharp HealthCare 31
Not applicableEnded earlyNCT04566965
What this trial is testing

Serology to COVID-19 for Recording Exposures and Evaluating Needs

Who this might be right for
Covid19CoronavirusSARS-CoV Infection
Children's Hospital Medical Center, Cincinnati 232
Testing effectiveness (Phase 2)Study completedNCT04375098
What this trial is testing

Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
Pontificia Universidad Catolica de Chile 58
Large-scale testing (Phase 3)Study completedNCT04611802
What this trial is testing

Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 33,000
Not applicableUnknownNCT04438837
What this trial is testing

Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Post-Exposure Prophylaxis
Rambam Health Care Campus 582
Testing effectiveness (Phase 2)Study completedNCT04376684
What this trial is testing

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

Who this might be right for
Severe Acute Respiratory Syndrome
GlaxoSmithKline 1,156
Large-scale testing (Phase 3)Study completedNCT06729593
What this trial is testing

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 87
Testing effectiveness (Phase 2)Looking for participantsNCT04442191
What this trial is testing

Convalescent Plasma as a Possible Treatment for COVID-19

Who this might be right for
COVID-19
University of Illinois at Chicago 50
Testing effectiveness (Phase 2)Study completedNCT04701710
What this trial is testing

Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
Maria de los Angeles Peral de Bruno 300
Large-scale testing (Phase 3)UnknownNCT04423042
What this trial is testing

Tocilizumab in Coronavirus-19 Positive Patients

Who this might be right for
Covid19COVID-19Severe Acute Respiratory Syndrome Coronavirus 2+2 more
University of Calgary 30
Early research (Phase 1)Ended earlyNCT05475821
What this trial is testing

Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants

Who this might be right for
Healthy Volunteers
AbbVie 24
Large-scale testing (Phase 3)UnknownNCT04648800
What this trial is testing

Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland

Who this might be right for
Covid19BCG Vaccination ReactionSARS-CoV Infection
Hanna Czajka 1,000
Not applicableUnknownNCT04584593
What this trial is testing

Pilot Study to Detect SARS-CoV-2 Virus in Sperm

Who this might be right for
Covid19
University Hospital, Toulouse 50
Not applicableStudy completedNCT04817280
What this trial is testing

COVID-19 in Polish Ice Swimmers.

Who this might be right for
Covid19SARS-CoV InfectionResistance, Disease+2 more
Wroclaw Medical University 2,534
Not applicableLooking for participantsNCT04448145
What this trial is testing

Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

Who this might be right for
COVID-19Corona Virus InfectionSARS-CoV 2
Columbia University 800
Large-scale testing (Phase 3)Study completedNCT04501783
What this trial is testing

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
R-Pharm 168
Testing effectiveness (Phase 2)Study completedNCT04323527
What this trial is testing

Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2

Who this might be right for
SARS-CoV InfectionSevere Acute Respiratory Syndrome (SARS) Pneumonia
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 278
Early research (Phase 1)Study completedNCT04522986
What this trial is testing

An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 Infection

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
Rohto Pharmaceutical Co., Ltd. 6
Next Page